Search

BOSTON – A study of more than 350 competitive athletes with implantable cardioverter defibrillators (ICDs) from around the world showed for the first time that sports may be safer for this group than has been thought.  There were no occurrences of death or injury due to arrhythmia or shock during sports in this group.  Additionally, only ten percent of the athletes received a shock during competition or practice and of those, most continued to play, as reported today at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions.

The meeting will present current and future management on sudden cardiac death, new drug and ablation treatment for atrial fibrillation, pacing and ICD advances, cardiac resynchronization techniques, remote patient monitoring, and advances in neuromodulation for heart failure and hypertension. The well received certificate Cardiac Rhythm Management Course will continue, and new courses on EPS/ECG added.

BOSTON – The Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) release the PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern.  The expert consensus statement presented today at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions, provides first-of-its-kind clinical practice guidelines on the evaluation and management of asymptomatic young patients with a WPW electrocardiographic pattern.

BOSTON – A retrospective analysis of data from the OMNI Registry, a large-scale, longitudinal registry of nearly 3,000 heart device patients, revealed that primary prevention non-evidence-based (NEB) implantable cardioverter-defibrillator (ICD) recipients had similar therapeutic benefits and outcomes as evidence-based (EB) ICD recipients.  These findings are being presented today at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions.